Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-644-2 | CAS number: 1633-22-3
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- Dichlorotricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene, mixed isomers
- EC Number:
- 249-236-8
- EC Name:
- Dichlorotricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene, mixed isomers
- Cas Number:
- 28804-46-8
- Molecular formula:
- C16H14Cl2
- IUPAC Name:
- Unknown constituents
- Test material form:
- solid: granular
1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 5 males and 5 females
Administration / exposure
- Vehicle:
- other: pulverised and moistened with 0.2 mL freshly collected RO water
- Details on dermal exposure:
- The test item was held in contact with the skin using porous gauze dressing and a non-irritating tape throughout the 24 h exposure period.
- Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females/2000 mg/kg bw
Results and discussion
Effect levels
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortality was observed in rats treated with 2000 mg DPX-C (Di-Cloro-Di-p-Xililene)/kg body weight.
- Clinical signs:
- No treatment related clinical signs were observed in any of the rats treated with 2000 mg DPX-C (Di-Cloro-Di-p-Xililene)/kg body weight.
- Body weight:
- All the male rats showed no appreciable change in mean body weight while decrease in the mean body weight was observed in female rats on day 7 which was increased on day 14 when compared to day 0 mean body weight treated with 2000 mg DPX-C (Di-Cloro-Di-p-Xililene)/kg body weight.
- Gross pathology:
- External
External examination of terminally sacrificed rats did not reveal any abnormality.
Internal
Visceral examination of terminally sacrificed rats did not reveal any lesion.
In the absence of any lesion in terminally sacrificed rats, it is concluded that the test item did not produce any treatment related effect at the dose level used in the present study.
Applicant's summary and conclusion
- Interpretation of results:
- other: Category 5 or Unclassified (GHS 2015)
- Conclusions:
- No mortality was observed following dermal application of 2000 mg DPX-C (Di-Cloro-Di-p-Xililene)/kg body weight. The acute dermal LD50 of DPX-C (Di-Cloro-Di-p-Xililene) in Wistar male and female rats was found to be greater than 2000 mg/kg body weight.
- Executive summary:
In an acute dermal toxicity study, a group of 8 to 13 weeks old Wistar rats (5 males and 5 females) was dermally exposed toDPX-C (Di-Cloro-Di-p-Xililene)for 24 h following applicationat a limit dose of 2000 mg/kg body weight. The required amount (506.8 to 598.6 mg) ofDPX-C (Di-Cloro-Di-p-Xililene)(pulverised and moistened with 0.2 mL freshly collected RO water)was applied over the clipped area (approximately7 × 5 cm body surface area) and the rats were observed for a period of 14 days.
There were no treatment-related mortality, clinical signs and necropsy findings recorded.
All the male rats showed no appreciable change in mean body weight while decrease in the mean body weight was observed in female rats on day 7 which was increased on day 14 when compared to day 0 mean body weight treated with 2000 mg DPX-C (Di-Cloro-Di-p-Xililene)/kg body weight.
The acute dermal median lethal dose (LD50) ofDPX-C (Di-Cloro-Di-p-Xililene)in Wistar rats (males and females) was found to be greater than 2000 mg/kg body weight.
Based on the results of this study, an indication of the classificationforDPX-C (Di-Cloro-Di-p-Xililene)isas follows:
Globally Harmonized System of Classification and Labelling of Chemicals (GHS 2015): Category 5 or Unclassified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
